Pfizer Income Statement (2009-2026) | PFE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jul2021	Oct2021	Dec2021	Apr2022	Jul2022	Sep2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	18.90B	24.04B	3.42B	25.66B	27.74B		3.26B	3.63B	3.49B		3.43B	14.88B	13.28B	0.44B		2.11B	2.27B	2.30B	17.56B	2.34B
Cost of Revenue (Quarter)	7.00B	9.93B		9.98B	8.65B			4.89B	3.24B		7.56B	3.38B	3.30B	5.26B		2.85B	3.78B	4.17B	5.27B	3.55B
Gross Profit (Quarter)	11.90B	14.10B		15.68B	19.09B			-1.26B	0.25B		-4.13B	11.50B	9.98B	-4.82B		-0.73B	-1.50B	-1.87B	12.29B	-1.21B
Operating items
Amortization - Intangibles (Quarter)	0.92B	0.97B		0.83B	0.82B			1.10B	1.18B		1.27B	1.31B	1.31B	1.31B		1.21B	1.21B	1.22B	1.23B	1.18B
Research & Development (Quarter)	2.24B	2.68B		2.30B	2.81B			2.50B	2.65B		2.81B	2.49B	2.70B	2.60B		2.20B	2.48B	2.55B	3.21B	2.49B
Selling, General & Administrative (Quarter)	2.92B	2.90B		2.59B	3.05B			3.42B	3.50B		4.58B	3.50B	3.72B	3.24B		3.03B	3.42B	3.19B	4.16B	2.96B
Restructuring Costs (Quarter)	-0.00B	0.64B		0.19B	0.19B			-0.04B	0.14B		1.59B	0.01B	1.10B	0.31B		0.68B	-0.07B	0.24B	0.77B	0.05B
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	5.16B	6.22B		5.09B	6.05B			5.88B	6.28B		8.98B	6.00B	7.52B	6.16B		5.91B	5.82B	5.97B	8.13B	5.50B
Operating Income (Quarter)	6.74B	7.88B		10.59B	13.04B			-7.14B	-6.03B		-13.11B	5.50B	2.47B	-10.98B		-6.64B	-7.33B	-7.84B	4.15B	-6.71B
EBIT (Quarter)	6.74B	7.88B		10.59B	13.04B			-7.14B	-6.03B		-13.11B	5.50B	2.47B	-10.98B		-6.64B	-7.33B	-7.84B	4.15B	-6.71B
Non-operating items
Other Non Operating Income (Quarter)	1.34B	1.70B		-0.35B	-0.77B			-0.28B	0.07B		0.16B	-0.68B	-1.11B	-0.24B		-0.95B	-0.74B	-0.52B	-4.51B	-0.86B
Non Operating Income (Quarter)	1.34B	1.70B		-0.35B	-0.77B			-0.28B	0.07B		0.16B	-0.68B	-1.11B	-0.24B		-0.95B	-0.74B	-0.52B	-4.51B	-0.86B
Net income details
EBT (Quarter)	6.95B	7.84B		9.05B	11.45B			6.27B	2.27B		-4.13B	3.42B	-0.10B	4.71B		2.79B	3.04B	3.33B	-1.64B	3.17B
Tax Provisions (Quarter)	1.12B	-0.33B		1.17B	1.57B			0.71B	-0.07B		-0.78B	0.29B	-0.13B	0.23B		-0.19B	0.14B	-0.22B	-0.00B	0.46B
Profit After Tax (Quarter)	5.83B	8.16B	0.58B	7.86B	9.91B		0.23B	0.50B	0.38B		0.06B	3.13B	0.04B	4.46B		2.97B	2.91B	3.55B	-1.63B	2.71B
Income from Non-Controlling Interests (Quarter)	0.03B	0.01B		0.01B	0.01B			0.01B	0.01B		0.01B	0.01B	0.01B	0.01B		0.01B	0.02B	0.01B	0.01B	0.01B
Income from Continuing Operations (Quarter)	5.83B	8.17B		7.88B	9.88B			5.55B	2.34B		-3.35B	3.13B	0.03B	4.48B		2.97B	2.90B	3.55B	-1.64B	2.71B
Consolidated Net Income (Quarter)	-0.24B	-0.01B		-0.01B	0.03B			0.00B	-0.00B		-0.03B	-0.01B	0.02B	-0.01B			0.03B			-0.01B
Income towards Parent Company (Quarter)	-0.24B	-0.01B		-0.01B	0.03B			0.00B	-0.00B		-0.03B	-0.01B	0.02B	-0.01B			0.03B			-0.01B
Net Income towards Common Stockholders (Quarter)	-0.24B	-0.01B		-0.01B	0.03B			0.00B	-0.00B		-0.03B	-0.01B	0.02B	-0.01B			0.03B			-0.01B
Additional items
EPS (Basic) (Quarter)	-0.04	0.00		0.00	0.01			0.00	0.00		0.00	0.00	0.00	0.00			0.00			0.00
EPS (Diluted) (Quarter)	-0.04	0.00		0.00	0.01			0.00	0.00		0.00	0.00	0.00	0.00			0.00			0.00
Shares Outstanding (Quarter)	5.60B	5.61B	5.60B	5.62B	5.59B	5.59B	5.61B	5.63B	5.65B	5.65B	5.64B	5.66B	5.67B	5.67B	5.66B	5.67B	5.68B	5.68B	5.68B	5.69B
Shares Outstanding (Diluted) (Quarter)	5.68B	5.72B	5.71B	5.76B	5.71B	5.71B	5.73B	5.73B	5.71B	5.71B	5.71B	5.70B	5.70B	5.71B	5.70B	5.71B	5.71B	5.71B	5.71B	5.73B
EBITDA (Quarter)	6.74B	7.88B		10.59B	13.04B			-7.14B	-6.03B		-13.11B	5.50B	2.47B	-10.98B		-6.64B	-7.33B	-7.84B	4.15B	-6.71B
Tax Rate (Quarter)	16.16%	-4.18%		12.95%	13.72%			11.40%	-3.13%		18.89%	8.56%	130.10%	4.96%		-6.79%	4.63%	-6.48%	0.12%	14.54%

Research Tools

Developers

Pfizer Income Statement (2009-2026) | PFE

Research Tools

Developers

Pfizer Income Statement (2009-2026) | PFE

Create an account

Sign In

Reset Password